Frequently Asked Questions
Does Semaglutide work for weight loss?
Yes. After treating so many patients personally, the documentation speaks for itself. People's recorded weights tend to all go down when taking this treatment regularly, and for more than a few weeks.
Is it safe?
As with any treatment there are side effects. We consult various peer reviewed sources to get an idea of what adverse drug reactions (ADRs) we can expect. The treatment appears to be well tolerated by most patients, and common side effects encountered in practice have been occasional nausea, constipation.
How does it work?
- Mimics GLP-1: Semaglutide mimics the action of the glucagon-like peptide-1 (GLP-1) hormone, which is naturally released after eating.
- Increases Insulin Secretion: It stimulates the pancreas to release insulin when blood sugar levels are high, helping to lower glucose levels.
- Reduces Glucagon Release: It suppresses the release of glucagon, a hormone that raises blood sugar by prompting the liver to release stored glucose.
- Slows Gastric Emptying: It delays the movement of food from the stomach to the intestines, which helps control post-meal blood sugar spikes and promotes a feeling of fullness.
- Appetite Suppression: By acting on the brain's appetite regulation centers, it reduces hunger, aiding in weight loss [1]
How do you take it?
Subcutaneously, which is not the same as intramuscular. It uses a 4mm needle 32guage into one of a few locations of fat on your body. Typically we recommend you alternate sites, and we offer full education on this as needed.
Fee Schedule 7/2025
| Weeks | Dose (mg/week) | Medication Cost | Visit/Consultation | Total |
|---|---|---|---|---|
| Weeks 1-4 | 0.25 | $300.00 | $131.00 | $431.00 |
| Weeks 5-8 | 0.5 | $400.00 | $88.00 | $488.00 |
| Weeks 9-12 | 1.0 | $600.00 | $88.00 | $688.00 |
| Weeks 13-16 | 1.7 | $620.00 | $88.00 | $708.00 |
| Weeks 17-20 | 2.4 | $640.00 | $88.00 | $728.00 |
Email us with any questions: fax@eastcountyim.com
Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021.
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- Very Low LDL-C Improves Risk of MACE in Patients With ASCVD, With Michelle O'Donoghue, MDon November 29, 2025 at 12:02 am
... benefits for patients,” O'Donoghue said. “Mainly, I think it would ... Semaglutide Provides Cardiorenal Benefits in CKD With or Without Diabetes.
- Highly Anticipated Alzheimer's Trials Yield Disappointing Results for GLP-1 Drug - MSNon November 28, 2025 at 9:22 pm
The oral GLP-1 receptor agonist semaglutide (Rybelsus) did not slow ... benefits in cognitively unimpaired people, with or without amyloid ...
- Tezepelumab Drastically Reduces OCS Use for Asthma in Open-Label Trial | HCPLiveon November 28, 2025 at 7:23 pm
... benefits may be partially explained by placebo effects seen in SOURCE. ... Semaglutide Provides Cardiorenal Benefits in CKD With or Without Diabetes.
- Novo Nordisk Rises On IRA Pricing Relief - Self Employedon November 28, 2025 at 7:19 pm
Semaglutide-based products have surged in demand due to significant weight loss and metabolic benefits reported in studies and clinical use. They also ...
- What is 'Ozempic 2.0,' the new needle-free weight-loss pill everyone's talking abouton November 28, 2025 at 6:55 pm
Meanwhile, Novo Nordisk experienced a setback when its oral semaglutide failed to show meaningful benefit in slowing Alzheimer's progression in two ...